Dr. Martin Gleave awarded with the Doctors of BC Terry Fox Medal
Dr. Gleave has made outstanding contributions to global cancer research as a uniquely gifted surgeon and scientist.
News
Dr. Poul Sorensen appointed as an ambassador of the Technical University of Munich
Congratulations to Dr. Poul Sorensen, a UBC Professor of Pathology and a Distinguished Scientist at BC Cancer, for being appointed as an International Ambassador to the Technical University of Munich (TUM), in Germany. These prestigious Ambassadorships are given by TUM to renowned international researchers that have formally conducted research at TUM, and who have retained particularly close ties to the university.
BC Cancer investigators receive support from the Osteosarcoma Institute
Congratulations to Drs. Poul Sorensen and Gregg Morin, at BC Cancer, and Dr. Wei Li, at the University of Pittsburgh, for being awarded $500,000 USD from the Osteosarcoma Institute for their project titled “Harnessing the osteosarcoma surfaceome for immunotherapy targets to block metastatic capacity”
BC Cancer researchers leading the development of immunotherapies targeting the surface protein IL1RAP for the treatment of Ewing sarcoma
Dr. Poul Sorensen, Distinguished Scientist at BC Cancer, in collaboration with Dr. Kevin Hay, Clinician-Ccientist at BC Cancer, and Dr. Wei Li, Assistant Professor at the University of Pittsburgh, received support from the Rutledge Cancer Foundation to develop and optimize novel immunotherapies targeting the surface protein IL1RAP for the treatment of Ewing sarcoma.
Dr. Florian Kuchenbauer recognized with UBC outstanding academic performance for 2022
We are thrilled to announce that Dr. Florian Kuchenbauer, distinguished scientist of Terry Fox Laboratory (Kuchenbauer Lab) and associate professor at University of British Columbia, has been honored with the Outstanding Academic Performance (OAP) award from the UBC Faculty of Medicine in 2022.
High impact publication from Andrew Wu and Ryan Yen, Colling Stevens Laboratory
Students of Dr. Xiaoyan Jiang, Andrew Wu and Ryan Yen (Collings Stevens Laboratory), along with a team of researchers, have published a paper in Leukemia Journal titled, "Identification of Multivariable microRNA and Clinical Biomarker Panels to Predict Imatinib Response in Chronic Myeloid Leukemia at Diagnosis."
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.